ABT-670 is a drug which acts as a potent orally bioavailable dopamine agonist selective for the D4 subtype which was developed as a possible treatment for erectile dysfunction although its current uses are limited to scientific research.
This page contains content from the copyrighted Wikipedia article "ABT-670"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
